Received a data breach letter?
Attorney-Led Notice Review · Received a Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”) notification letter? Review your options with our legal team.
Join Now →Free, Confidential Case Review
If you received a data breach notification letter from Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”), send us your details and a member of the legal team will review your request. There is no cost or obligation.
No fee unless you recover.
Sending this form does not create an attorney-client relationship.
Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, "MFMA") operate at the highly specialized intersection of maternal-fetal medicine, advanced obstetric and gynecological imaging, and comprehensive women's healthcare. Because of the critical nature of their clinical operations, these affiliated practices routinely collect and maintain vast repositories of extraordinarily sensitive patient files. This includes comprehensive obstetrical histories, complex fetal ultrasound and imaging records, detailed diagnostic evaluations, genetic screening results, and personal demographic information. The intimate and specialized nature of the medical care provided means that patients trust MFMA with some of the most private, vulnerable aspects of their personal lives and health histories, necessitating a corresponding duty of absolute data security. In 2025, MFMA reported a significant security incident to the Massachusetts Attorney General, bringing to light a breach that compromises the digital defenses safeguarding this sensitive repository of patient information. While investigations into healthcare sector cyberattacks typically point toward sophisticated network intrusions, unauthorized system access, or vulnerabilities introduced via third-party digital vendors and cloud-hosted medical databases, the reality of such a breach underscores the profound risks associated with digitized medical records. Healthcare providers remain prime targets for malicious cybercriminals due to the immense black-market value of medical data, which can be leveraged for various fraudulent schemes long after a network perimeter has been breached. The exposure of protected health information and personally identifiable information in this breach creates immediate, multi-faceted risks for every affected patient. Compromised data fields typically encompass full names, dates of birth, Social Security numbers, medical record numbers, health insurance details, and highly sensitive clinical diagnosis and treatment notes. Unlike a stolen credit card, a compromised medical record or Social Security number cannot simply be cancelled and reissued. This data exposes victims to severe, long-term threats of medical identity theft—where unauthorized actors obtain treatment under a victim's name, corrupting their official medical history—as well as financial fraud, tax refund scams, and targeted phishing attacks utilizing specific details about their healthcare providers and medical conditions. Under federal and state law, healthcare entities like MFMA are bound by strict legal mandates to secure patient data against unauthorized access and disclosure. The Health Insurance Portability and Accountability Act (HIPAA), alongside Massachusetts data privacy statutes, requires covered entities and their business associates to implement robust administrative, physical, and technical safeguards. These obligations include conducting regular security risk assessments, maintaining encrypted databases, enforcing strict access controls, and swiftly patching known system vulnerabilities. A data breach of this magnitude serves as a strong indicator that these critical legal safeguards may have failed, raising serious questions about whether institutional security protocols met the required standard of care. Receiving a formal data breach notification letter from MFMA is a serious legal development; it serves as an official admission by the healthcare provider that your confidential information was compromised while under their direct care and control. Legally, the receipt of this letter establishes the foundational standing required to participate in a class action lawsuit aimed at holding the organization accountable for its security failures. Crucially, affected individuals do not need to demonstrate that they have already suffered actual financial loss or identity theft to pursue legal remedies; the increased, imminent risk of future harm is sufficient under the law. Our firm is actively investigating potential class action claims on behalf of patients whose data was exposed, operating strictly on a contingency fee basis—meaning you pay nothing out of pocket, and there are no fees unless we successfully recover compensation for you.
About the Notice You Received
This case page tracks a Massachusetts public filing connected to Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”), filed July 17, 2025. If you received a data breach notification letter, notice, or mailing from this company, keep it with the date it was received and any enrollment information it contains.
The case record identifies the information described in the filing as potentially exposed. The recorded jurisdiction is Massachusetts, where M.G.L. c. 93H governs breach notifications.
DataBreachCaseReview.com focuses on attorney-led reviews of notification letters. A review can help you understand the information in your notice, document questions for the legal team, and assess potential next steps. It does not guarantee that a lawsuit has been filed or that you will qualify for a claim.
This notice may also be referred to as:
It Takes 2 Minutes
Tell us you received a notification letter from Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”). No need to have the letter handy — just your name and contact info.
A licensed data breach attorney will review your eligibility within 24 hours and contact you directly. Completely free, no obligation.
If a claim is appropriate, the legal team will explain your options and any applicable deadlines. You pay nothing unless there is a recovery on your behalf.
Why This Breach Matters
Healthcare organizations store a combination of medical and financial data that makes breach victims vulnerable to both traditional identity theft and medical identity fraud. Stolen insurance identifiers can be used to obtain prescriptions, procedures, or durable medical equipment billed to your insurer — and medical identity fraud can go undetected for years, affecting future coverage and billing.
Massachusetts residents are protected by M.G.L. c. 93H, which gives you the right to pursue legal remedies when a company fails to adequately protect your data.
Common Questions
I received a Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”) breach notice — does it mean my data was stolen?
Yes. Receiving a Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”) data breach letter, notice, or notification mailing means your personal information was accessed or exposed without authorization. Companies are only required to send these notices when a confirmed breach occurred affecting your data specifically.
Is there a deadline to act after receiving my Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”) notification letter?
Yes. Massachusetts and federal law impose statutes of limitations on data breach claims. Once a class action lawsuit is filed by another attorney, the window to be a named plaintiff typically closes quickly. Submitting a free case review now ensures you are positioned before those windows pass. There is no cost and no obligation to find out if you qualify.
How much does it cost to pursue a claim?
Nothing upfront. Representation is 100% contingency-based — a fee is only collected if your case results in compensation. If there is no recovery, you owe nothing at any stage.
Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”) was required by law to notify you because your personal data was compromised. That letter is evidence of harm — and the foundation for a legal claim.
Data breach claims have deadlines. The sooner you act after receiving your letter, the better positioned you are to participate and recover.
By joining with other Maternal Fetal Medicine Associates, Carnegie Imaging for Women, Carnegie South Imaging for Women, and Carnegie Women’s Health (collectively, “MFMA”) letter recipients, you have access to legal resources that would be too costly to pursue individually.
You never pay attorney fees out of pocket. Our representation is 100% contingency-based — we only get paid if you recover compensation.
No Fee Unless You Recover
A member of the legal team is available to answer your questions. Or scroll to the top to submit your case review form — free and no obligation.